- Home
- GNL vs CNTA Comparison
GNL vs CNTA Comparison
Compare GNL & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNL
- CNTA
- Stock Information
- Founded
- GNL 2011
- CNTA 2020
- Country
- GNL United States
- CNTA United Kingdom
- Employees
- GNL N/A
- CNTA 86
- Industry
- GNL Real Estate Investment Trusts
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- GNL Real Estate
- CNTA Health Care
- Exchange
- GNL Nasdaq
- CNTA Nasdaq
- Market Cap
- GNL 1.7B
- CNTA 1.6B
- IPO Year
- GNL N/A
- CNTA 2021
- Fundamental
- Price
- GNL $7.47
- CNTA $12.43
- Analyst Decision
- GNL Buy
- CNTA Strong Buy
- Analyst Count
- GNL 4
- CNTA 11
- Target Price
- GNL $9.50
- CNTA $27.00
- AVG Volume (30 Days)
- GNL 1.7M
- CNTA 1.2M
- Earning Date
- GNL 08-05-2025
- CNTA 08-12-2025
- Dividend Yield
- GNL 13.64%
- CNTA N/A
- EPS Growth
- GNL N/A
- CNTA N/A
- EPS
- GNL N/A
- CNTA N/A
- Revenue
- GNL $789,545,000.00
- CNTA $15,000,000.00
- Revenue This Year
- GNL N/A
- CNTA N/A
- Revenue Next Year
- GNL N/A
- CNTA N/A
- P/E Ratio
- GNL N/A
- CNTA N/A
- Revenue Growth
- GNL 38.85
- CNTA 118.88
- 52 Week Low
- GNL $6.51
- CNTA $8.46
- 52 Week High
- GNL $9.11
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- GNL 44.42
- CNTA 47.36
- Support Level
- GNL $7.21
- CNTA $11.77
- Resistance Level
- GNL $7.85
- CNTA $13.06
- Average True Range (ATR)
- GNL 0.16
- CNTA 0.70
- MACD
- GNL -0.04
- CNTA 0.03
- Stochastic Oscillator
- GNL 40.31
- CNTA 51.21
About GNL Global Net Lease Inc.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.